Ocular syphilis in patients with human immunodeficiency virus/acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy

Purpose: Re-emergent ocular syphilis in patients with Human immunodeficiency virus (HIV) co-infection has both diagnostic and management difficulties because of the overlapping risk factors. The clinical manifestations described in non-HIV may not be the same in patients with HIV coinfection. Immune...

Full description

Bibliographic Details
Main Authors: Sridharan Sudharshan, Nitin K Menia, Poongulali Selvamuthu, Mudit Tyagi, N Kumarasamy, Jyotirmay Biswas
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2020-01-01
Series:Indian Journal of Ophthalmology
Subjects:
Online Access:http://www.ijo.in/article.asp?issn=0301-4738;year=2020;volume=68;issue=9;spage=1887;epage=1893;aulast=Sudharshan
_version_ 1817983296266567680
author Sridharan Sudharshan
Nitin K Menia
Poongulali Selvamuthu
Mudit Tyagi
N Kumarasamy
Jyotirmay Biswas
author_facet Sridharan Sudharshan
Nitin K Menia
Poongulali Selvamuthu
Mudit Tyagi
N Kumarasamy
Jyotirmay Biswas
author_sort Sridharan Sudharshan
collection DOAJ
description Purpose: Re-emergent ocular syphilis in patients with Human immunodeficiency virus (HIV) co-infection has both diagnostic and management difficulties because of the overlapping risk factors. The clinical manifestations described in non-HIV may not be the same in patients with HIV coinfection. Immune recovery uveitis (IRU) may also alter the course of the disease causing recurrences. We studied the clinical features in correlation with CD4 counts, systemic immune status, sexual preferences and management outcomes in HIV/AIDS patients with ocular syphilis in the highly active antiretroviral treatment (HAART) era from a high endemic HIV population like India. Methods: Retrospective analysis of all patients with ocular syphilis and HIV/AIDS seen between 2016 and 2019 was done. Results: A total of 33 patients (56 eyes) with a CD4 count range of 42–612 cells/cu.mm were included. Ocular syphilis was found to be higher in individuals with high risk behavior such as men who have sex with men (MSMs) (45%). Panuveitis was the commonest manifestation (53.57%) and was even the presenting feature of HIV and syphilis in many patients. Significant vitritis, usually uncommon in HIV/AIDS immunocompromised patients was noted even with low CD4 counts in patients with ocular syphilis. Significant correlation was noted between ocular presentation and CD4 counts (P < 0.05). Conclusion: Ocular syphilis presents differently in patients with HIV/AIDS. Diffuse retinitis is seen commonly in low counts (<100 cells/cu.mm). Classical placoid chorioretinitis lesions usually described in non-HIV individuals is uncommon in HIV patients and is seen in higher CD4 counts ( >400 cells/cu.mm). Ocular manifestations can be an indicator of the immune status of the patient. Not all patients with ocular manifestations have associated features of systemic syphilis. Ocular manifestations can be the first presentation of HIV/AIDS. Although, there is good response to systemic penicillin and HAART, recurrences and immune recovery uveitis (IRU) can also occur.
first_indexed 2024-04-13T23:31:30Z
format Article
id doaj.art-4cf926dd73ee4122ad0fd7d56b0fee95
institution Directory Open Access Journal
issn 0301-4738
1998-3689
language English
last_indexed 2024-04-13T23:31:30Z
publishDate 2020-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Indian Journal of Ophthalmology
spelling doaj.art-4cf926dd73ee4122ad0fd7d56b0fee952022-12-22T02:24:54ZengWolters Kluwer Medknow PublicationsIndian Journal of Ophthalmology0301-47381998-36892020-01-016891887189310.4103/ijo.IJO_1070_20Ocular syphilis in patients with human immunodeficiency virus/acquired immunodeficiency syndrome in the era of highly active antiretroviral therapySridharan SudharshanNitin K MeniaPoongulali SelvamuthuMudit TyagiN KumarasamyJyotirmay BiswasPurpose: Re-emergent ocular syphilis in patients with Human immunodeficiency virus (HIV) co-infection has both diagnostic and management difficulties because of the overlapping risk factors. The clinical manifestations described in non-HIV may not be the same in patients with HIV coinfection. Immune recovery uveitis (IRU) may also alter the course of the disease causing recurrences. We studied the clinical features in correlation with CD4 counts, systemic immune status, sexual preferences and management outcomes in HIV/AIDS patients with ocular syphilis in the highly active antiretroviral treatment (HAART) era from a high endemic HIV population like India. Methods: Retrospective analysis of all patients with ocular syphilis and HIV/AIDS seen between 2016 and 2019 was done. Results: A total of 33 patients (56 eyes) with a CD4 count range of 42–612 cells/cu.mm were included. Ocular syphilis was found to be higher in individuals with high risk behavior such as men who have sex with men (MSMs) (45%). Panuveitis was the commonest manifestation (53.57%) and was even the presenting feature of HIV and syphilis in many patients. Significant vitritis, usually uncommon in HIV/AIDS immunocompromised patients was noted even with low CD4 counts in patients with ocular syphilis. Significant correlation was noted between ocular presentation and CD4 counts (P < 0.05). Conclusion: Ocular syphilis presents differently in patients with HIV/AIDS. Diffuse retinitis is seen commonly in low counts (<100 cells/cu.mm). Classical placoid chorioretinitis lesions usually described in non-HIV individuals is uncommon in HIV patients and is seen in higher CD4 counts ( >400 cells/cu.mm). Ocular manifestations can be an indicator of the immune status of the patient. Not all patients with ocular manifestations have associated features of systemic syphilis. Ocular manifestations can be the first presentation of HIV/AIDS. Although, there is good response to systemic penicillin and HAART, recurrences and immune recovery uveitis (IRU) can also occur.http://www.ijo.in/article.asp?issn=0301-4738;year=2020;volume=68;issue=9;spage=1887;epage=1893;aulast=Sudharshanhivaidsmen who have sex with men (msm)necrotizing retinitisocular syphilispenicillinplacoid chorioretinitishaart
spellingShingle Sridharan Sudharshan
Nitin K Menia
Poongulali Selvamuthu
Mudit Tyagi
N Kumarasamy
Jyotirmay Biswas
Ocular syphilis in patients with human immunodeficiency virus/acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy
Indian Journal of Ophthalmology
hiv
aids
men who have sex with men (msm)
necrotizing retinitis
ocular syphilis
penicillin
placoid chorioretinitis
haart
title Ocular syphilis in patients with human immunodeficiency virus/acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy
title_full Ocular syphilis in patients with human immunodeficiency virus/acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy
title_fullStr Ocular syphilis in patients with human immunodeficiency virus/acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy
title_full_unstemmed Ocular syphilis in patients with human immunodeficiency virus/acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy
title_short Ocular syphilis in patients with human immunodeficiency virus/acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy
title_sort ocular syphilis in patients with human immunodeficiency virus acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy
topic hiv
aids
men who have sex with men (msm)
necrotizing retinitis
ocular syphilis
penicillin
placoid chorioretinitis
haart
url http://www.ijo.in/article.asp?issn=0301-4738;year=2020;volume=68;issue=9;spage=1887;epage=1893;aulast=Sudharshan
work_keys_str_mv AT sridharansudharshan ocularsyphilisinpatientswithhumanimmunodeficiencyvirusacquiredimmunodeficiencysyndromeintheeraofhighlyactiveantiretroviraltherapy
AT nitinkmenia ocularsyphilisinpatientswithhumanimmunodeficiencyvirusacquiredimmunodeficiencysyndromeintheeraofhighlyactiveantiretroviraltherapy
AT poongulaliselvamuthu ocularsyphilisinpatientswithhumanimmunodeficiencyvirusacquiredimmunodeficiencysyndromeintheeraofhighlyactiveantiretroviraltherapy
AT mudittyagi ocularsyphilisinpatientswithhumanimmunodeficiencyvirusacquiredimmunodeficiencysyndromeintheeraofhighlyactiveantiretroviraltherapy
AT nkumarasamy ocularsyphilisinpatientswithhumanimmunodeficiencyvirusacquiredimmunodeficiencysyndromeintheeraofhighlyactiveantiretroviraltherapy
AT jyotirmaybiswas ocularsyphilisinpatientswithhumanimmunodeficiencyvirusacquiredimmunodeficiencysyndromeintheeraofhighlyactiveantiretroviraltherapy